Laloglu E., & Alay H. (2022). Endocan as a potential marker in diagnosis and predicting disease severity in COVID-19 patients: a promising biomarker for patients with false-negative RT-PCR. Upsala Journal of Medical Sciences, 127(1). https://doi.org/10.48101/ujms.v127.8211